Prasun Chakraborty

Company: Genevation

Job title: Chief Scientific Officer

Seminars:

Revolutionising Cancer Treatment: AI-Driven Personalised Vaccines 9:00 am

Introducing AI-mediated personalised cancer vaccine platform Overviewing the proprietary neoantigen identification process that reduces development time to two weeks Implementing competitive differentiation through AI-driven vaccine design and rapid deploymentRead more

day: Day Two

Roundtable Discussion: Leveraging Technological Advances, Novel Manufacturing Approaches & External Partners to Safeguard Production Timeliness & Enhance the Quality of Autologous Neoantigen Therapies 2:30 pm

Considering manufacturing and quality control testing of personalised neoantigen platforms to guide platform choice for autologous therapies Turning to novel manufacturing technologies such as cell-free DNA production for rapid therapeutic manufacture whilst maintaining purity and regulatory adherence Evaluating quality, production efficiency and cost of external suppliers to make informed partnering decisionsRead more

day: Day Two